Literature DB >> 18512010

Differential expression of pro-inflammatory cytokines and a pro-apoptotic protein in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis.

R F Leal1, C S R Coy, M L S Ayrizono, J J Fagundes, M Milanski, M J Saad, L A Velloso, J R N Góes.   

Abstract

BACKGROUND: Pouchitis after total rectocolectomy is among the most common complications of patients with ulcerative colitis (UC). However, its frequency is quite rare in patients with familial adenomatous polyposis (FAP). We evaluated the inflammatory and pro-apoptotic activity in endoscopically normal mucosa of the ileal pouch in patients with UC and FAP.
METHODS: Twenty patients (10 with UC and 10 with FAP) with "J" pouch after total proctocolectomy were studied as were 10 normal controls. Biopsies were obtained from the mucosa of the pouch of UC and FAP patients and from the normal ileum of controls. The expression levels of TNF-alpha, IL-1beta, IL-6, IL-8 and phospho-BAD were determined by immunoblotting. Activated NFkappaB was evaluated by immuno-precipitation and immunoblotting for IkappaB kinase beta.
RESULTS: Patients with UC had higher levels of IL-1beta, IL-6, IL-8 and TNF-alpha than patients with FAP. The level of TNF-alpha was higher in patients with UC than in patients with FAP; both patient groups had TNF-alpha levels higher than controls. Activation of NFkappaB was similar in all three groups. The expression of phospho-BAD was significantly lower in patients with FAP than in patients with UC.
CONCLUSIONS: As compared with patients with FAP, patients with UC presented increased levels of some pro-inflammatory cytokines, even in the absence of clinical or endoscopic signs of pouchitis. Patients with FAP presented lower levels of pro-inflammatory proteins and of phospho-BAD. These findings may explain the higher rates of progression to pouchitis in UC patients, which could correlate with mucosal atrophy that occurs in inflamed tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18512010     DOI: 10.1007/s10151-008-0395-9

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  49 in total

1.  Enhanced mucosal cytokine production in inflammatory bowel disease.

Authors:  W E Pullman; S Elsbury; M Kobayashi; A J Hapel; W F Doe
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

Review 2.  Apoptosis: mechanisms and relevance in cancer.

Authors:  Katrien Vermeulen; Dirk R Van Bockstaele; Zwi N Berneman
Journal:  Ann Hematol       Date:  2005-07-22       Impact factor: 3.673

3.  Cross-talk between the insulin and angiotensin signaling systems.

Authors:  L A Velloso; F Folli; X J Sun; M F White; M J Saad; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

Review 4.  Restorative proctocolectomy with various types of reservoir.

Authors:  R J Nicholls
Journal:  World J Surg       Date:  1987-12       Impact factor: 3.352

5.  Proctocolectomy without ileostomy for ulcerative colitis.

Authors:  A G Parks; R J Nicholls
Journal:  Br Med J       Date:  1978-07-08

6.  Pouchitis.

Authors:  Jan-Erik Akerlund; Robert Löfberg
Journal:  Curr Opin Gastroenterol       Date:  2004-07       Impact factor: 3.287

7.  Association between fecal hydrogen sulfide production and pouchitis.

Authors:  Hiroki Ohge; Julie K Furne; John Springfield; David A Rothenberger; Robert D Madoff; Michael D Levitt
Journal:  Dis Colon Rectum       Date:  2005-03       Impact factor: 4.585

Review 8.  Pouchitis: pathophysiology and treatment.

Authors:  T Kühbacher; S Schreiber; N Runkel
Journal:  Int J Colorectal Dis       Date:  1998       Impact factor: 2.571

9.  Cytokine production in pouchitis is similar to that in ulcerative colitis.

Authors:  R T Patel; I Bain; D Youngs; M R Keighley
Journal:  Dis Colon Rectum       Date:  1995-08       Impact factor: 4.585

10.  In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes.

Authors:  I Colditz; R Zwahlen; B Dewald; M Baggiolini
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

View more
  10 in total

Review 1.  Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.

Authors:  Bo Shen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802

2.  Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes.

Authors:  Jeffrey D McCurdy; Edward V Loftus; William J Tremaine; Thomas C Smyrk; David H Bruining; Darrell S Pardi; Laura E Raffals; John B Kisiel; Nayantara Coelho-Prabhu; Sunanda V Kane; William A Faubion; Konstantinos A Papadakis
Journal:  Inflamm Bowel Dis       Date:  2013-10       Impact factor: 5.325

3.  Activation of signal transducer and activator of transcription-1 (STAT-1) and differential expression of interferon-gamma and anti-inflammatory proteins in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis.

Authors:  R F Leal; M L S Ayrizono; M Milanski; A Coope; J J Fagundes; L A Velloso; C S R Coy
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

4.  Differential expression of TLR2, TLR4 and JNK in mucosa of ileal pouches for ulcerative colitis. Is there a role for bacterial antigen pathway in asymptomatic patients?

Authors:  Nielce M de Paiva; Maria L S Ayrizono; Marciane Milanski; Andressa Coope; Luiza M F Oliveira; João J Fagundes; Lício A Velloso; Cláudio S R Coy; Raquel F Leal
Journal:  Int J Clin Exp Med       Date:  2011-09-15

Review 5.  Pouchitis: insight into the pathogenesis and clinical aspects.

Authors:  Leandro Minatel Vidal de Negreiros; Lívia Bitencourt Pascoal; Lívia Moreira Genaro; Julian Furtado Silva; Bruno Lima Rodrigues; Michel Gardere Camargo; Carlos Augusto Real Martinez; Cláudio Saddy Rodrigues Coy; Maria de Lourdes Setsuko Ayrizono; João José Fagundes; Raquel Franco Leal
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

6.  Detection of epithelial apoptosis in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis.

Authors:  Raquel F Leal; Maria de Lourdes S Ayrizono; Marciane Milanski; João J Fagundes; Juliana C Moraes; Luciana R Meirelles; Lício A Velloso; Cláudio S R Coy
Journal:  J Transl Med       Date:  2010-01-29       Impact factor: 5.531

7.  Recombinant human beta 2-defensin fusion proteins as a tool to investigate defensin structure and function in small human intestinal tissue samples.

Authors:  Annekatrin Coordes; Andreas Andreou; Ulrike Erben; Thorsten Stroh; Katja Blunert; Nadia Slavova; Britta Siegmund; Heinz-Johannes Buhr; Anton J Kroesen
Journal:  Inflamm Res       Date:  2012-08-26       Impact factor: 4.575

8.  Therapeutic effects of triptolide via the inhibition of IL-1β expression in a mouse model of ulcerative colitis.

Authors:  Haifeng Zhang; Chen Gong; Lishuai Qu; Xiaoling Ding; Wei Cao; Haiqin Chen; Bin Zhang; Guoxiong Zhou
Journal:  Exp Ther Med       Date:  2016-06-30       Impact factor: 2.447

9.  Ileal pouch of ulcerative colitis and familial adenomatous polyposis patients exhibit modulation of autophagy markers.

Authors:  Nielce Maria Paiva; Lívia Bitencourt Pascoal; Leandro Minatel Vidal Negreiros; Mariana Portovedo; Andressa Coope; Maria de Lourdes Setsuko Ayrizono; Claudio Saddy Rodrigues Coy; Marciane Milanski; Raquel Franco Leal
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

Review 10.  Incidence and Risk Factors of Cancer in the Anal Transitional Zone and Ileal Pouch following Surgery for Ulcerative Colitis and Familial Adenomatous Polyposis.

Authors:  Guillaume Le Cosquer; Etienne Buscail; Cyrielle Gilletta; Céline Deraison; Jean-Pierre Duffas; Barbara Bournet; Géraud Tuyeras; Nathalie Vergnolle; Louis Buscail
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.